Abstract P228: Preclinical pharmacokinetics and pharmacodynamics of KB-0742, a selective, oral CDK9 inhibitor
2000 ◽
Vol 102
(s176)
◽
pp. 74-84
◽
2017 ◽
Vol 42
(6)
◽
pp. 891-901
◽
2015 ◽
Vol 54
(2)
◽
pp. 133-146
◽
2011 ◽
Vol 36
(3)
◽
pp. 129-139
◽
2020 ◽
Vol 47
(6)
◽
pp. 855.e11-855.e12
Keyword(s):